NO942920L - Reversering av flerlegemiddelresistens med trifenylazasykloalkanderivater - Google Patents
Reversering av flerlegemiddelresistens med trifenylazasykloalkanderivaterInfo
- Publication number
- NO942920L NO942920L NO942920A NO942920A NO942920L NO 942920 L NO942920 L NO 942920L NO 942920 A NO942920 A NO 942920A NO 942920 A NO942920 A NO 942920A NO 942920 L NO942920 L NO 942920L
- Authority
- NO
- Norway
- Prior art keywords
- integer
- multidrug resistance
- tumors
- triphenylazacycloalkane
- reversal
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D207/06—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with radicals, containing only hydrogen and carbon atoms, attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
- C07D211/10—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with radicals containing only carbon and hydrogen atoms attached to ring carbon atoms
- C07D211/14—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with radicals containing only carbon and hydrogen atoms attached to ring carbon atoms with hydrocarbon or substituted hydrocarbon radicals attached to the ring nitrogen atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
- C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D223/00—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom
- C07D223/02—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom not condensed with other rings
- C07D223/04—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom not condensed with other rings with only hydrogen atoms, halogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Hydrogenated Pyridines (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
Forbindelse av formelen (CH2)m (CH2)qCH .Ph2 Ph3 (CH2)r PtU hvori Phj, Ph2 og Ph3 hver er en fenyl- gruppe eventuelt substituert med en kombinasjon av opptil tre medlemmer av gruppen bestående av fluor, klor, brom, hydroksy, trifluormetyl, NH2, N(CH3)2, (C^Jalkyl og (Cj.Jalkoksy, eller fen- ylgruppen kan være substituert med en j metylendioksygruppe; n er et helt tall fra l til 5; m er O eller et helt tali ; fra l til 2; og q er et helt tall fra l til 2; eller et syreaddisjonssalt derav, som reverserer flerlegemiddel- resistens i flerlegemiddelresistente tumorceller, og er således anvendbare adjuvanser ved behandling av tumorer. Disse forbindelser fungerer tilsynelat- ende ved inhibering av en P-glykopro- teinpumpe som blir aktivert i et sent i trinn for tumorutvikling og som således er til stede i tumorer fra visse opp- rinnelser.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US83254092A | 1992-02-06 | 1992-02-06 | |
PCT/US1993/000669 WO1993016044A1 (en) | 1992-02-06 | 1993-01-11 | Reversal of multi-drug resistance by triphenyl-azacycloalkane derivatives |
Publications (2)
Publication Number | Publication Date |
---|---|
NO942920L true NO942920L (no) | 1994-08-05 |
NO942920D0 NO942920D0 (no) | 1994-08-05 |
Family
ID=25261950
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO942920A NO942920L (no) | 1992-02-06 | 1994-08-05 | Reversering av flerlegemiddelresistens med trifenylazasykloalkanderivater |
Country Status (14)
Country | Link |
---|---|
EP (1) | EP0643693B1 (no) |
JP (1) | JPH07503957A (no) |
KR (1) | KR950700248A (no) |
AT (1) | ATE182582T1 (no) |
AU (1) | AU662602B2 (no) |
CA (1) | CA2129144C (no) |
DE (1) | DE69325805T2 (no) |
DK (1) | DK0643693T3 (no) |
ES (1) | ES2135463T3 (no) |
GR (1) | GR3031557T3 (no) |
HU (1) | HUT70564A (no) |
NO (1) | NO942920L (no) |
NZ (1) | NZ249040A (no) |
WO (1) | WO1993016044A1 (no) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU679723B2 (en) * | 1993-01-21 | 1997-07-10 | Merrell Dow Pharmaceuticals Inc. | Diarylalkyl piperidines useful as multi-drug resistant tumoragents |
US5670521A (en) * | 1994-08-05 | 1997-09-23 | Merrell Pharmaceuticals Inc. | Reversal of multi-drug resistance by triphenyl-azacycloalkane derivatives |
EP1129707A3 (en) | 1994-08-31 | 2002-02-27 | Deutsches Krebsforschungszentrum Stiftung des öffentlichen Rechts | Methods for identifying and treating resistant tumors |
TW527186B (en) | 1996-03-19 | 2003-04-11 | Janssen Pharmaceutica Nv | Fused imidazole derivatives as multidrug resistance modulators |
GB0003685D0 (en) * | 2000-02-17 | 2000-04-05 | Univ Cardiff | Sensitisation of cellular material |
CN110372571B (zh) * | 2018-04-12 | 2022-11-15 | 中国科学院大连化学物理研究所 | 一种2-(2,2-二芳基乙基)-环胺衍生物或盐及合成和应用与组合物 |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE1049377B (de) * | 1952-04-03 | 1959-01-29 | Abbott Laboratories, North Chicago, 111. (V. St. A.) | Verfahren zur Herstellung von substituierten Vinylpiperidinen |
EP0228893A3 (en) * | 1985-12-20 | 1990-01-03 | A.H. ROBINS COMPANY, INCORPORATED (a Delaware corporation) | Arylalkyl-heterocyclic amines, n-substituted by aryloxyalkyl group in allergy treatment |
DE69003200T2 (de) * | 1989-06-19 | 1994-01-20 | Wellcome Found | Arylsubstituierte Aminderivate verwendbar in der Krebstherapie. |
GB9000305D0 (en) * | 1990-01-06 | 1990-03-07 | Pfizer Ltd | Anticholinergic agents |
EP0467435A3 (en) * | 1990-07-19 | 1992-04-01 | Akzo N.V. | Benzhydryl derivatives having calmodulin inhibitor properties |
AU679723B2 (en) * | 1993-01-21 | 1997-07-10 | Merrell Dow Pharmaceuticals Inc. | Diarylalkyl piperidines useful as multi-drug resistant tumoragents |
-
1993
- 1993-01-11 ES ES93903678T patent/ES2135463T3/es not_active Expired - Lifetime
- 1993-01-11 JP JP5514096A patent/JPH07503957A/ja active Pending
- 1993-01-11 DE DE69325805T patent/DE69325805T2/de not_active Expired - Fee Related
- 1993-01-11 CA CA002129144A patent/CA2129144C/en not_active Expired - Fee Related
- 1993-01-11 WO PCT/US1993/000669 patent/WO1993016044A1/en active IP Right Grant
- 1993-01-11 AU AU34842/93A patent/AU662602B2/en not_active Ceased
- 1993-01-11 NZ NZ249040A patent/NZ249040A/en unknown
- 1993-01-11 EP EP93903678A patent/EP0643693B1/en not_active Expired - Lifetime
- 1993-01-11 AT AT93903678T patent/ATE182582T1/de not_active IP Right Cessation
- 1993-01-11 HU HU9402298A patent/HUT70564A/hu unknown
- 1993-01-11 DK DK93903678T patent/DK0643693T3/da active
-
1994
- 1994-08-05 NO NO942920A patent/NO942920L/no unknown
- 1994-08-05 KR KR1019940702687A patent/KR950700248A/ko not_active Application Discontinuation
-
1999
- 1999-10-15 GR GR990402651T patent/GR3031557T3/el unknown
Also Published As
Publication number | Publication date |
---|---|
EP0643693B1 (en) | 1999-07-28 |
GR3031557T3 (en) | 2000-01-31 |
CA2129144C (en) | 1999-07-13 |
KR950700248A (ko) | 1995-01-16 |
NO942920D0 (no) | 1994-08-05 |
DK0643693T3 (da) | 1999-11-29 |
CA2129144A1 (en) | 1993-08-19 |
EP0643693A1 (en) | 1995-03-22 |
AU662602B2 (en) | 1995-09-07 |
ES2135463T3 (es) | 1999-11-01 |
DE69325805D1 (de) | 1999-09-02 |
HU9402298D0 (en) | 1994-10-28 |
WO1993016044A1 (en) | 1993-08-19 |
ATE182582T1 (de) | 1999-08-15 |
AU3484293A (en) | 1993-09-03 |
NZ249040A (en) | 1997-06-24 |
JPH07503957A (ja) | 1995-04-27 |
DE69325805T2 (de) | 2000-03-16 |
HUT70564A (en) | 1995-10-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE60220188D1 (de) | Hemmer des phosphattransports | |
ATE203747T1 (de) | 5-azabicyclo(3.1.0.)hexylalkyl-2-piperidone und - glutarimide als neurokinin receptor antagonisten. | |
DK0724566T3 (da) | 1,2-Diarylcyclopentenylforbindelser til behandling af inflammation | |
AR020250A1 (es) | Compueto de isoxazolinona, composicion farmaceutica que lo comprende y su uso para preparar dicha composicion | |
DK0731796T3 (da) | 1,3,5-Trisubstituerede pyrozolforbindelser til behandling af inflammation | |
ATE334973T1 (de) | Chinazolinverbindungen | |
NO942920L (no) | Reversering av flerlegemiddelresistens med trifenylazasykloalkanderivater | |
SE8503466L (sv) | Aminofenolforeningar | |
TR200400237T4 (tr) | Yeni karışımlar. | |
SE8503415D0 (sv) | Novel isoindolinyl-alkyl-piperazines | |
BG101601A (en) | Pharmaceutical piperazine compounds | |
ATE44648T1 (de) | Antihypertensives kombinationspraeparat. | |
KR960700230A (ko) | 다중-약물 내성종양 제제로서 유용한 디아릴알킬 피페리딘(Diarylalkyl piperidines useful as multi-drug resistant tumor agents) | |
NO963213L (no) | Endotelinreseptorantagonister | |
DE60103129D1 (de) | Benzofurancarboxamide und deren therapeutische verwendung | |
FI910511A0 (fi) | Foerfarande foer framstaellning av substituerade b-diketoner. | |
TR200100364T2 (tr) | Yeni bileşimler. | |
FI850969L (fi) | Monosilylerade aminofenyletylaminderivat, foerfarande foer deras framstaellning och deras anvaendning vid befraemjandet av tillvaext. | |
ES2037833T3 (es) | 2-amino-5-hidroxi-4-pirimidonas. | |
DE69217148D1 (de) | Isoxazole derivate als lichtschutzmittel | |
EA200300460A1 (ru) | НОВЫЕ ПРОИЗВОДНЫЕ м-АМИНОФЕНИЛИМИНОИМИДАЗОЛИДИНА ДЛЯ ЛЕЧЕНИЯ НЕДЕРЖАНИЯ МОЧИ | |
TH76780A (th) | อนุพันธ์ของไดออกแซน-2-อิลแอลคิลคาร์บาเมท, สารเตรียมของสารเหล่านั้น และการใช้สารเหล่านั้นทางการรักษา | |
FI872110A0 (fi) | Antihypertensiviska aemnen, dessa innehaollande farmaceutiska blandningar och foerfarande foer framstaellning av aemnen och blandningar. | |
UA37177C2 (uk) | Гетероциклічні сполуки або їх фармацевтично прийнятні адитивні солі кислоти або n-оксид гетероциклічної сполуки або його адитивна сіль кислоти | |
TH13641A (th) | เบนโซไพรานและแอนทาโกนิสของ ltb4 ที่สัมพันธ์กัน |